(UBS) UBS - Ratings and Ratios

Exchange: NYSE • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0244767585

Investment Advice, Wealth Planning, Banking, Investment Management, Lending

UBS EPS (Earnings per Share)

EPS (Earnings per Share) of UBS over the last years for every Quarter: "2020-09-30": 0.56, "2020-12-31": 0.46, "2021-03-31": 0.49, "2021-06-30": 0.55, "2021-09-30": 0.63, "2021-12-31": 0.38, "2022-03-31": 0.61, "2022-06-30": 0.61, "2022-09-30": 0.52, "2022-12-31": 0.5, "2023-03-31": 0.32, "2023-06-30": -0.02, "2023-09-30": -0.24, "2023-12-31": -0.51, "2024-03-31": 0.52, "2024-06-30": 0.34, "2024-09-30": 0.53, "2024-12-31": 0.39, "2025-03-31": 0.6, "2025-06-30": 0.82,

UBS Revenue

Revenue of UBS over the last years for every Quarter: 2020-09-30: 8181, 2020-12-31: 8183, 2021-03-31: 8675, 2021-06-30: 8895, 2021-09-30: 9015, 2021-12-31: 8716, 2022-03-31: 9382, 2022-06-30: 8067, 2022-09-30: 7956, 2022-12-31: 7988, 2023-03-31: 8698, 2023-06-30: 9509, 2023-09-30: 10644, 2023-12-31: 10417, 2024-03-31: 11941, 2024-06-30: 11853, 2024-09-30: 10960, 2024-12-31: 10556, 2025-03-31: 10935.197, 2025-06-30: 18582,

Description: UBS UBS

UBS Group AG is a global financial services company providing a wide range of financial solutions to private, institutional, and corporate clients. The companys diverse business model is organized into five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. This structure enables UBS to offer comprehensive financial services, including investment advice, wealth planning, corporate banking, and investment management.

Key Performance Indicators (KPIs) that can be used to evaluate UBSs performance include revenue growth, net profit margin, return on equity (RoE), and cost-income ratio. With a RoE of 5.86%, UBS is generating returns that are somewhat modest compared to some of its peers, suggesting there may be opportunities for improvement in profitability. The companys diversified business model is a strength, as it allows UBS to capitalize on various market opportunities and manage risks across different business lines.

UBSs Asset Management and Investment Bank divisions are critical components of its business, providing a range of products and services such as equities, fixed income, hedge funds, and alternative investment strategies. The companys ability to offer customized multi-asset solutions and advisory services is a key differentiator. Additionally, UBSs Global Wealth Management division is a significant contributor to its revenue, providing wealth management services to high net worth individuals.

From a valuation perspective, UBSs price-to-earnings (P/E) ratio of 22.36 and forward P/E of 17.92 suggest that the stock may be moderately valued relative to its earnings. The companys market capitalization of $107.65 billion indicates a significant presence in the global financial services industry. Overall, UBSs diversified business model, global reach, and range of financial services position it as a major player in the industry.

UBS Stock Overview

Market Cap in USD 129,081m
Sub-Industry Diversified Capital Markets
IPO / Inception 2014-11-21

UBS Stock Ratings

Growth Rating 90.1%
Fundamental 56.1%
Dividend Rating 44.1%
Return 12m vs S&P 500 23.2%
Analyst Rating 2.50 of 5

UBS Dividends

Dividend Yield 12m 3.72%
Yield on Cost 5y 13.59%
Annual Growth 5y -6.39%
Payout Consistency 66.8%
Payout Ratio 57.9%

UBS Growth Ratios

Growth Correlation 3m 97.2%
Growth Correlation 12m 71.8%
Growth Correlation 5y 95.9%
CAGR 5y 43.35%
CAGR/Max DD 3y 1.61
CAGR/Mean DD 3y 10.70
Sharpe Ratio 12m 1.46
Alpha 0.00
Beta 0.918
Volatility 23.65%
Current Volume 1408.7k
Average Volume 20d 1603.3k
Stop Loss 40.1 (-3.2%)
Signal 0.90

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (6.28b TTM) > 0 and > 6% of Revenue (6% = 3.06b TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA 5.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -994.5% (prev -1189 %; Δ 194.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.11 (>3.0%) and CFO 185.93b > Net Income 6.28b (YES >=105%, WARN >=100%)
Net Debt (204.02b) to EBITDA (17.73b) ratio: 11.50 <= 3.0 (WARN <= 3.5)
Current Ratio 0.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (3.31b) change vs 12m ago -1.57% (target <= -2.0% for YES)
Gross Margin 37.42% (prev 98.78%; Δ -61.36pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 3.16% (prev 2.87%; Δ 0.29pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 0.46 (EBITDA TTM 17.73b / Interest Expense TTM 30.67b) >= 6 (WARN >= 3)

Altman Z'' -1.72

(A) -0.30 = (Total Current Assets 410.45b - Total Current Liabilities 917.96b) / Total Assets 1669.99b
(B) 0.05 = Retained Earnings (Balance) 79.73b / Total Assets 1669.99b
(C) 0.01 = EBIT TTM 14.12b / Avg Total Assets 1615.48b
(D) 0.05 = Book Value of Equity 85.55b / Total Liabilities 1580.29b
Total Rating: -1.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 56.10

1. Piotroski 3.50pt = -1.50
2. FCF Yield 78.92% = 5.0
3. FCF Margin data missing
4. Debt/Equity 3.81 = -1.83
5. Debt/Ebitda 19.17 = -2.50
6. ROIC - WACC (= -1.16)% = -1.45
7. RoE 7.21% = 0.60
8. Rev. Trend 82.23% = 6.17
9. EPS Trend 32.39% = 1.62

What is the price of UBS shares?

As of September 18, 2025, the stock is trading at USD 41.43 with a total of 1,408,662 shares traded.
Over the past week, the price has changed by +3.29%, over one month by +4.38%, over three months by +31.19% and over the past year by +46.02%.

Is UBS a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, UBS is currently (September 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 56.10 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UBS is around 55.05 USD . This means that UBS is currently undervalued and has a potential upside of +32.87% (Margin of Safety).

Is UBS a buy, sell or hold?

UBS has received a consensus analysts rating of 2.50. Therefor, it is recommend to sell UBS.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the UBS price?

Issuer Target Up/Down from current
Wallstreet Target Price 38.5 -7%
Analysts Target Price 38.5 -7%
ValueRay Target Price 58.7 41.7%

Last update: 2025-09-13 05:05

UBS Fundamental Data Overview

Market Cap USD = 129.08b (129.08b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 236.19b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 21.5503
P/E Forward = 14.4509
P/S = 2.7458
P/B = 1.4519
P/EG = 0.595
Beta = 0.932
Revenue TTM = 51.03b USD
EBIT TTM = 14.12b USD
EBITDA TTM = 17.73b USD
Long Term Debt = 307.98b USD (from longTermDebt, last quarter)
Short Term Debt = 31.93b USD (from shortTermDebt, last quarter)
Debt = 339.90b USD (Calculated: Short Term 31.93b + Long Term 307.98b)
Net Debt = 204.02b USD (from netDebt column, last quarter)
Enterprise Value = 232.79b USD (129.08b + Debt 339.90b - CCE 236.19b)
Interest Coverage Ratio = 0.46 (Ebit TTM 14.12b / Interest Expense TTM 30.67b)
FCF Yield = 78.92% (FCF TTM 183.72b / Enterprise Value 232.79b)
FCF Margin = 360.0% (FCF TTM 183.72b / Revenue TTM 51.03b)
Net Margin = 12.31% (Net Income TTM 6.28b / Revenue TTM 51.03b)
Gross Margin = 37.42% ((Revenue TTM 51.03b - Cost of Revenue TTM 31.94b) / Revenue TTM)
Tobins Q-Ratio = 2.72 (Enterprise Value 232.79b / Book Value Of Equity 85.55b)
Interest Expense / Debt = 2.01% (Interest Expense 6.82b / Debt 339.90b)
Taxrate = 24.56% (1.68b / 6.82b)
NOPAT = 10.65b (EBIT 14.12b * (1 - 24.56%))
Current Ratio = 0.45 (Total Current Assets 410.45b / Total Current Liabilities 917.96b)
Debt / Equity = 3.81 (Debt 339.90b / last Quarter total Stockholder Equity 89.28b)
Debt / EBITDA = 19.17 (Net Debt 204.02b / EBITDA 17.73b)
Debt / FCF = 1.85 (Debt 339.90b / FCF TTM 183.72b)
Total Stockholder Equity = 87.14b (last 4 quarters mean)
RoA = 0.38% (Net Income 6.28b, Total Assets 1669.99b )
RoE = 7.21% (Net Income TTM 6.28b / Total Stockholder Equity 87.14b)
RoCE = 3.57% (Ebit 14.12b / (Equity 87.14b + L.T.Debt 307.98b))
RoIC = 2.52% (NOPAT 10.65b / Invested Capital 422.76b)
WACC = 3.68% (E(129.08b)/V(468.98b) * Re(9.39%)) + (D(339.90b)/V(468.98b) * Rd(2.01%) * (1-Tc(0.25)))
Shares Correlation 3-Years: -6.06 | Cagr: -0.12%
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.57% ; FCFE base≈141.63b ; Y1≈109.86b ; Y5≈70.13b
Fair Price DCF = 332.1 (DCF Value 1052.52b / Shares Outstanding 3.17b; 5y FCF grow -26.71% → 3.0% )
EPS Correlation: 32.39 | EPS CAGR: 18.01% | SUE: -0.27 | # QB: 0
Revenue Correlation: 82.23 | Revenue CAGR: 36.13% | SUE: N/A | # QB: None

Additional Sources for UBS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle